Patents Assigned to New York University Medical Center and Centocor, Inc.
  • Publication number: 20020141996
    Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor&agr; (TNF&agr;) and are useful in vivo diagnosis and therapy of a number of TNF&agr;-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
    Type: Application
    Filed: January 10, 2002
    Publication date: October 3, 2002
    Applicant: New York University Medical Center and Centocor, Inc.
    Inventors: Junming Le, Jan Vilcek, Peter Daddona, John Ghrayeb, David Knight, Scott Siegel